Gray BH - Search Results

1

The association between ischemic and jeopardized myocardia and all-cause mortality in patients with peripheral artery disease.

Hammad TA, Yousefzai R, Venkatachalam S, Lowry A, Gornik HL, Jaber W, Bartholomew JR, Kim SH, Cerqueira M, Gray BH, Blackstone EH, Shishehbor MH. Hammad TA, et al. Among authors: gray bh. Vasc Med. 2016 Apr;21(2):113-9. doi: 10.1177/1358863X15623629. Epub 2016 Jan 21. Vasc Med. 2016. PMID: 26797315

2

Role of the cardiologist in peripheral vascular disease.

Olin JW, Young JR, Graor RA, Ruschhaupt WF, Bartholomew JR, Gray BH. Olin JW, et al. Among authors: gray bh. J Am Coll Cardiol. 1992 Jan;19(1):235-6. doi: 10.1016/0735-1097(92)90082-x. J Am Coll Cardiol. 1992. PMID: 1729340 Free article. No abstract available.

3

Safety and efficacy of thrombolytic therapy for superior vena cava syndrome.

Gray BH, Olin JW, Graor RA, Young JR, Bartholomew JR, Ruschhaupt WF. Gray BH, et al. Chest. 1991 Jan;99(1):54-9. doi: 10.1378/chest.99.1.54. Chest. 1991. PMID: 1984986

4

The treatment of iliac artery atherosclerosis with angioplasty and intravascular stents.

Gray BH, Sullivan T. Gray BH, et al. Vasc Med. 1996;1(4):287-91. doi: 10.1177/1358863X9600100408. Vasc Med. 1996. PMID: 9552585 Review. No abstract available.

5

Large artery occlusive disease.

Bartholomew JR, Gray BH. Bartholomew JR, et al. Among authors: gray bh. Rheum Dis Clin North Am. 1999 Aug;25(3):669-86, ix. doi: 10.1016/s0889-857x(05)70092-2. Rheum Dis Clin North Am. 1999. PMID: 10467634 Review.

6

Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure.

Gray BH, Olin JW, Childs MB, Sullivan TM, Bacharach JM. Gray BH, et al. Vasc Med. 2002;7(4):275-9. doi: 10.1191/1358863x02vm456oa. Vasc Med. 2002. PMID: 12710843

7

Invasive treatment of chronic limb ischemia according to the Lower Extremity Grading System (LEGS) score: a 6-month report.

Kalbaugh CA, Taylor SM, Cull DL, Blackhurst DW, Gray BH, Langan EM 3rd, Dellinger MB, McClary GE Jr, Jackson MR, Carsten CG 3rd, Snyder BA, York JW, Youkey JR. Kalbaugh CA, et al. Among authors: gray bh. J Vasc Surg. 2004 Jun;39(6):1268-76. doi: 10.1016/j.jvs.2004.02.009. J Vasc Surg. 2004. PMID: 15192568 Free article.

8

Does a standardization tool to direct invasive therapy for symptomatic lower extremity peripheral arterial disease improve outcomes?

Androes MP, Kalbaugh CA, Taylor SM, Blackhurst DW, McClary GE Jr, Gray BH, Langan EM 3rd, Caldwell RA, Hanover TM, York JW, Stanbro MD, Youkey JR. Androes MP, et al. Among authors: gray bh. J Vasc Surg. 2004 Nov;40(5):907-15. doi: 10.1016/j.jvs.2004.08.046. J Vasc Surg. 2004. PMID: 15557904 Free article.

9

The utility of the StarClose arterial closure device in patients with peripheral arterial disease.

Gray BH, Miller R, Langan EM 3rd, Joels CS, Yasin Y, Kalbaugh CA. Gray BH, et al. Ann Vasc Surg. 2009 May-Jun;23(3):341-4. doi: 10.1016/j.avsg.2008.07.009. Epub 2008 Sep 21. Ann Vasc Surg. 2009. PMID: 18809287

10

The impact of isolated tibial disease on outcomes in the critical limb ischemic population.

Gray BH, Grant AA, Kalbaugh CA, Blackhurst DW, Langan EM 3rd, Taylor SA, Cull DL. Gray BH, et al. Ann Vasc Surg. 2010 Apr;24(3):349-59. doi: 10.1016/j.avsg.2009.07.034. Epub 2010 Jan 4. Ann Vasc Surg. 2010. PMID: 20045628

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters